BioGeometry raises over $100 million across Series A funding
Beijing-based BioGeometry plans to use new funding for molecular and cellular AI models, laboratory expansion and development of its own drug pipeline.
Search stories, companies and the ideas behind China’s AI.
Beijing-based BioGeometry plans to use new funding for molecular and cellular AI models, laboratory expansion and development of its own drug pipeline.
An October 28 edited conference dialogue sets out Chinese AI founders' views on continuous learning and enterprise post-training, rather than announcing a new model.
STAR Market Daily reports that Baidu plans to share world-model research progress, while the model's intended use and relationship to Apollo Go remain unclear.
An October 28 portfolio analysis by Xinzhineng Toutiao argues that Shunwei's robotics investments reach beyond robot bodies to components, training data and varied applications.
An October 27 QbitAI analysis examines which parts of RoboParty's RP1 humanoid research platform are available to developers and which remain under development or subject to repository limits.
WeRide has launched a global insurance partnership program with Allianz Insurance Singapore and Ping An P&C as its first partners, according to an October 27 IT Home report.